352 related articles for article (PubMed ID: 29237483)
1. Adipocytes promote cholangiocarcinoma metastasis through fatty acid binding protein 4.
Nie J; Zhang J; Wang L; Lu L; Yuan Q; An F; Zhang S; Jiao Y
J Exp Clin Cancer Res; 2017 Dec; 36(1):183. PubMed ID: 29237483
[TBL] [Abstract][Full Text] [Related]
2. FBXW7 suppresses epithelial-mesenchymal transition, stemness and metastatic potential of cholangiocarcinoma cells.
Yang H; Lu X; Liu Z; Chen L; Xu Y; Wang Y; Wei G; Chen Y
Oncotarget; 2015 Mar; 6(8):6310-25. PubMed ID: 25749036
[TBL] [Abstract][Full Text] [Related]
3. Tetraspanin 1 promotes epithelial-to-mesenchymal transition and metastasis of cholangiocarcinoma via PI3K/AKT signaling.
Wang Y; Liang Y; Yang G; Lan Y; Han J; Wang J; Yin D; Song R; Zheng T; Zhang S; Pan S; Liu X; Zhu M; Liu Y; Cui Y; Meng F; Zhang B; Liang S; Guo H; Liu Y; Hassan MK; Liu L
J Exp Clin Cancer Res; 2018 Dec; 37(1):300. PubMed ID: 30514341
[TBL] [Abstract][Full Text] [Related]
4. EGF/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition.
Clapéron A; Mergey M; Nguyen Ho-Bouldoires TH; Vignjevic D; Wendum D; Chrétien Y; Merabtene F; Frazao A; Paradis V; Housset C; Guedj N; Fouassier L
J Hepatol; 2014 Aug; 61(2):325-32. PubMed ID: 24704591
[TBL] [Abstract][Full Text] [Related]
5. Up-regulated LINC00261 predicts a poor prognosis and promotes a metastasis by EMT process in cholangiocarcinoma.
Gao J; Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Cui Y; Zhong X
Pathol Res Pract; 2020 Jan; 216(1):152733. PubMed ID: 31812439
[TBL] [Abstract][Full Text] [Related]
6. 14-3-3ζ and aPKC-ι synergistically facilitate epithelial-mesenchymal transition of cholangiocarcinoma via GSK-3β/Snail signaling pathway.
Yang Y; Liu Y; He JC; Wang JM; Schemmer P; Ma CQ; Qian YW; Yao W; Zhang J; Qi WP; Fu Y; Feng W; Yang T
Oncotarget; 2016 Aug; 7(34):55191-55210. PubMed ID: 27409422
[TBL] [Abstract][Full Text] [Related]
7. GATA6 promotes epithelial-mesenchymal transition and metastasis through MUC1/β-catenin pathway in cholangiocarcinoma.
Deng X; Jiang P; Chen J; Li J; Li D; He Y; Jiang Y; Zhang Y; Xu S; Li X; Wang S; Tian F
Cell Death Dis; 2020 Oct; 11(10):860. PubMed ID: 33060563
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-494-dependent WDHDI inhibition suppresses epithelial-mesenchymal transition, tumor growth and metastasis in cholangiocarcinoma.
Liu B; Hu Y; Qin L; Peng XB; Huang YX
Dig Liver Dis; 2019 Mar; 51(3):397-411. PubMed ID: 30314946
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-21 regulates biological behavior by inducing EMT in human cholangiocarcinoma.
Liu Z; Jin ZY; Liu CH; Xie F; Lin XS; Huang Q
Int J Clin Exp Pathol; 2015; 8(5):4684-94. PubMed ID: 26191158
[TBL] [Abstract][Full Text] [Related]
10. Adipocyte-Induced FABP4 Expression in Ovarian Cancer Cells Promotes Metastasis and Mediates Carboplatin Resistance.
Mukherjee A; Chiang CY; Daifotis HA; Nieman KM; Fahrmann JF; Lastra RR; Romero IL; Fiehn O; Lengyel E
Cancer Res; 2020 Apr; 80(8):1748-1761. PubMed ID: 32054768
[TBL] [Abstract][Full Text] [Related]
11. Annexin10 promotes extrahepatic cholangiocarcinoma metastasis by facilitating EMT via PLA2G4A/PGE2/STAT3 pathway.
Sun R; Liu Z; Qiu B; Chen T; Li Z; Zhang X; Xu Y; Zhang Z
EBioMedicine; 2019 Sep; 47():142-155. PubMed ID: 31492557
[TBL] [Abstract][Full Text] [Related]
12. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth.
Nieman KM; Kenny HA; Penicka CV; Ladanyi A; Buell-Gutbrod R; Zillhardt MR; Romero IL; Carey MS; Mills GB; Hotamisligil GS; Yamada SD; Peter ME; Gwin K; Lengyel E
Nat Med; 2011 Oct; 17(11):1498-503. PubMed ID: 22037646
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of long noncoding RNA H19 indicates a poor prognosis for cholangiocarcinoma and promotes cell migration and invasion by affecting epithelial-mesenchymal transition.
Xu Y; Wang Z; Jiang X; Cui Y
Biomed Pharmacother; 2017 Aug; 92():17-23. PubMed ID: 28528181
[TBL] [Abstract][Full Text] [Related]
14. YAP is a critical oncogene in human cholangiocarcinoma.
Pei T; Li Y; Wang J; Wang H; Liang Y; Shi H; Sun B; Yin D; Sun J; Song R; Pan S; Sun Y; Jiang H; Zheng T; Liu L
Oncotarget; 2015 Jul; 6(19):17206-20. PubMed ID: 26015398
[TBL] [Abstract][Full Text] [Related]
15. The H4 histamine receptor agonist, clobenpropit, suppresses human cholangiocarcinoma progression by disruption of epithelial mesenchymal transition and tumor metastasis.
Meng F; Han Y; Staloch D; Francis T; Stokes A; Francis H
Hepatology; 2011 Nov; 54(5):1718-28. PubMed ID: 21793031
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of FXR or TGR5 activation in cholangiocarcinoma progression.
Erice O; Labiano I; Arbelaiz A; Santos-Laso A; Munoz-Garrido P; Jimenez-Agüero R; Olaizola P; Caro-Maldonado A; Martín-Martín N; Carracedo A; Lozano E; Marin JJ; O'Rourke CJ; Andersen JB; Llop J; Gómez-Vallejo V; Padro D; Martin A; Marzioni M; Adorini L; Trauner M; Bujanda L; Perugorria MJ; Banales JM
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1335-1344. PubMed ID: 28916388
[TBL] [Abstract][Full Text] [Related]
17. Exogenous fatty acid binding protein 4 promotes human prostate cancer cell progression.
Uehara H; Takahashi T; Oha M; Ogawa H; Izumi K
Int J Cancer; 2014 Dec; 135(11):2558-68. PubMed ID: 24740818
[TBL] [Abstract][Full Text] [Related]
18. Utilization of adipocyte-derived lipids and enhanced intracellular trafficking of fatty acids contribute to breast cancer progression.
Yang D; Li Y; Xing L; Tan Y; Sun J; Zeng B; Xiang T; Tan J; Ren G; Wang Y
Cell Commun Signal; 2018 Jun; 16(1):32. PubMed ID: 29914512
[TBL] [Abstract][Full Text] [Related]
19. Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma.
Cadamuro M; Nardo G; Indraccolo S; Dall'olmo L; Sambado L; Moserle L; Franceschet I; Colledan M; Massani M; Stecca T; Bassi N; Morton S; Spirli C; Fiorotto R; Fabris L; Strazzabosco M
Hepatology; 2013 Sep; 58(3):1042-53. PubMed ID: 23505219
[TBL] [Abstract][Full Text] [Related]
20. aPKC-ι/P-Sp1/Snail signaling induces epithelial-mesenchymal transition and immunosuppression in cholangiocarcinoma.
Qian Y; Yao W; Yang T; Yang Y; Liu Y; Shen Q; Zhang J; Qi W; Wang J
Hepatology; 2017 Oct; 66(4):1165-1182. PubMed ID: 28574228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
